An Ask Me Anything with STAT’s Nicholas St. Fleur
Recently, STAT launched a brand-new home for our subscribers to connect with each other and with their favorite STAT journalists. It’s called, appropriately, STAT+ Connect.
Recently, STAT launched a brand-new home for our subscribers to connect with each other and with their favorite STAT journalists. It’s called, appropriately, STAT+ Connect.
Welcome to TDR’s review of the Top 5 Psychedelic Developments for the week of October 23. Aside from presenting a synopsis of events, we provide
Even before it was found to reduce pain and anxiety in modern times, music has been used for centuries to relieve pain. Now, researchers in
A team of University of Waterloo researchers has created smart, advanced materials that will be the building blocks for a future generation of soft medical
AbbVie today announced that the UK Medicines and Healthcare products Regulatory Agency has granted conditional Marketing Authorisation for Tepkinly® (epcoritamab) as a monotherapy for the
A sweeping new paper on menopause by a UVA Health expert and collaborators highlights the profound and sometimes surprising effects the “change of life” can
Artificial intelligence is making waves in the world of health and beyond. And there are multiple ways that it can help people with their wellbeing
The most comprehensive research into cholesterol ever conducted in the UK has found 54% of Brits could have high total cholesterol levels.
Complications of diabetes can have numerous negative health effects, from impaired vision and nerve damage to kidney dysfunction and heart disease.
GlobalData tracks drug-specific phase transition and likelihood of approval scores, in addition to indication benchmarks based off 18 years of historical drug development data. Attributes